DOCSLIB.ORG

Branch Meeting Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Branch Meeting Program 2020 Annual ASM Intermountain Branch Meeting ASM Intermountain Branch Meeting Hosted by Weber State University Saturday, December 5, 2020 Table of Contents Program ........................................................................................................................................................ 2 Keynote Address .......................................................................................................................................... 3 Oral Sessions ................................................................................................................................................. 4 Oral Session A—Career Panel .................................................................................................................. 5 Oral Session B—AAR, CIV, and CPHM ...................................................................................................... 7 Oral Session C—AES and EEB ................................................................................................................... 9 Oral Session D—POM and HMB ............................................................................................................. 10 Oral Session E—MBP .............................................................................................................................. 11 Employment Fair ........................................................................................................................................ 12 Poster Sessions ........................................................................................................................................... 15 Poster Session A—CIV and HMB ............................................................................................................ 16 Poster Session B—MBP .......................................................................................................................... 17 Poster Session C—AAR, CPHM, and EEB ............................................................................................... 18 Poster Session D—AES ........................................................................................................................... 20 Oral Abstracts ............................................................................................................................................. 21 Poster Abstracts ......................................................................................................................................... 51 Author Index ............................................................................................................................................... 80 1 Program 9:00 – 10:00 Opening Session (https://weber.zoom.us/s/93785843584) Welcome Keynote Address—Dr. Dustin L. Williams, PhD, “Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors” 10:00 – 11:30 Concurrent Oral Presentations Session A—Career Panel Session B—AAR, CIV, and CPHM Session C—AES and EEB Session D—POM and HMB Session E—MBP 11:30 – 12:15 Break for Lunch Employment Fair 12:15 – 1:00 Concurrent Poster Presentations Session A—CIV and HMB Session B—MBP Session C—AAR, CPHM, and EEB Session D—AES 1:00 – 1:30 Closing Session (https://weber.zoom.us/s/93785843584) Elections Memorials Awards 2 Keynote Address Title Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors Abstract Biofilm-related infections continue to complicate healthcare. For example, in cases of open fractures rates of infection have gone unchanged since their definition in the 1980s. This may be due to the inability of systemic antibiotics to achieve sufficient doses against biofilms that contaminate a wound site at the time of injury. All antibiotic therapies that are currently in clinical use have been developed, optimized and regulated for efficacy against planktonic bacteria. Novel strategies and technologies that target the biofilm phenotype may improve infection treatment and prevention. Work in our lab is multifaceted to address the biofilm problem including development of chemical compounds with potential to disperse and kill well-established biofilms, active release coatings that are optimized to eradicate biofilms, as well as a device to sustain local, high doses of antibiotic delivery. There is not likely any single method that will provide a solution, but as designs and devices are integrated into a polytherapy approach rates of biofilm- related infection may be reduced. Translational data from in vitro to in vivo testing indicates that the chemical and device approaches we are developing have promise to eradicate biofilms that contaminate and complicate sites of biofilm-related infection. The overall objective is to improve patient care and quality of life. Biography Dustin L. Williams, PhD is an Associate Professor in the Department of Orthopaedics at the University of Utah and a Research Scientist with the Department of Veterans Affairs. He fuses his degrees in Microbiology (BS) and Bioengineering (PhD) to develop antimicrobial technologies that target the biofilm phenotype. He has launched two companies—CŪRZA and Purgo Scientific—out of the U of Utah. The combination of translational science and commercialization is aimed at improving patient care, reducing rates of biofilm-related infection, and mitigating bone pathologies (e.g., heterotopic ossification) that may be influenced by the presence of biofilms. Zoom Link: https://weber.zoom.us/s/93785843584?pwd=d1hhMzVqdm1rRDQzdmpFdUJSOGJyUT09 Meeting ID: 937 8584 3584 Passcode: 769061 3 Oral Sessions 4 Oral Session A—Career Panel Purpose This panel will give attendees the opportunity to interact with career microbiologists. Each panelist will present the trajectory of his or her unique career. Attendees will then have the opportunity to solicit advice about pursuing a career in microbiology. Biographies Jeff Rogers is a Health Research Science Specialist with the U.S. Department of Veterans Affairs, within the Veterans Health Administration and University of Utah Division of Epidemiology. He currently performs epidemiological research within the Veterans healthcare system. He has experience in active-duty military service, hospital project management, microbiology research and data management roles. He is from South Ogden, UT and a husband and father of four children. He earned a BA degree from the University of Alaska Fairbanks and a BS degree from Weber State University in microbiology. He has also earned a master of health administration (MHA) degree from Capella University. He is currently finishing his master of public health (MPH) degree with a concentration in epidemiology from the University of Nebraska Medical Center. His interests are in infectious disease epidemiology, global health and management of infection control within hospital/clinical settings. Jessi Dōne is a Nationally Registered, Certified Microbiologist at the baccalaureate level. She specializes in Food Safety, Quality, Pharmaceutical and Medical Device. Jessi holds a Master of Business Administration degree from Weber State University, Ogden, Utah; an AACSB accredited school. Her work and leadership positions include years of Food Safety, Quality and Regulatory Management as a Sr. Quality and Food Safety Manager, and SQF Practitioner, within an Extruded, Baked and Canned Products Plant, as well as, Senior Microbiologist and Director of Laboratory Operations within Dietary Supplements and Medical Device fields. Jessi has built, implemented and maintained Food Safety and Quality Plans, within a large manufacturing facility with multiple processes. Throughout her career Jessi has further developed her skills through attendance in various seminars and certifications like Better Process Control School (BPCS), Principles of Internal Auditing, FSPCA Preventive Controls for Human Food and FSPCA Preventive Controls for Animal Food, Thermal Processing Course for Low Acid Canned Foods (21 CFR 113), and is a contributing member of the American Society of Quality (ASQ) and American Society of Microbiology (ASM). Jessi is a Safe Quality Food Institute (SQFI) body of knowledge consultant for food processing, manufacturing and packaging plants. Jessi currently sits on the Weber State Microbiology Advisory Board as the Co-Chair Vice President and enjoys sharing her broad base of the Sciences, Risk Management and Mitigation, and passion for education and Food Science. 5 Nicholas Ashton received a B.S., M.S. and Ph.D. in bioengineering at The University of Utah completing his doctoral dissertation on The Adhesive Silk of the Aquatic Caddisfly Larva, a work conducted in search of design principles for better surgical glues, vascular embolizing agents, and tough hydrogels. He completed a Postdoctoral Fellowship in the Bone and Biofilm Research Laboratory at the University of Utah under the tutelage of Dustin Williams, PhD, an expert in anti-biofilm technologies. To continue his work towards better infection prevention and treatment technologies, he recently accepted a Research Instructor position in The Department of Orthopedics at The University of Utah. His personal research focuses on identifying antibiofilm agents which have been overlooked because of the assay failures used in current clinical and commercial R&D laboratories. Chalice Gustavson has degrees in Chemistry, Criminal Justice, and Medical Laboratory Sciences from Weber State University and the University of Utah. She has had a variety
Load more

Recommended publications
  • Microbiology Media - Ready to Use, Prepared Plates
    Microbiology Media - Ready to use, prepared plates Ready poured plates, general purpose media Ready poured plate, general anaerobe agar 65 65 Columbia blood agar with neomycin. Chromogenic UTI medium Catalogue No Plate diameter, mm Pack qty Price Catalogue No Pack qty Price PO794A 90 10 12.55 PO219A 10 7.54 CLED medium Catalogue No Plate diameter, mm Pack qty Price Ready poured plate, Lactobacilli PO120A 90 10 5.75 64 CLED square plate Catalogue No Plate dimensions, mm Pack qty Price MRS Agar. OXPO0299L 120 x 120 10 16.92 CLED medium with andrades Catalogue No Plate diameter, mm Pack qty Price Catalogue No Plate diameter, mm Pack qty Price PO231A 90 10 7.30 PO121A 90 10 5.75 Columbia agar base Ready poured plates, Legionnella media Catalogue No Plate diameter, mm Pack qty Price 65 OXPO0537A 90 10 5.45 MacConkey agar with salt Legionella growth medium, BCYE Catalogue No Plate diameter, mm Pack qty Price Catalogue No Plate diameter, mm Pack qty Price PO149A 90 10 5.95 PO5072A 90 10 14.72 MacConkey agar without salt Legionella selective medium, BMPA Catalogue No Plate diameter, mm Pack qty Price Catalogue No Plate diameter, mm Pack qty Price PO148A 90 10 5.58 PO0324A 90 10 20.31 MacConkey agar No. 3 Catalogue No Plate diameter, mm Pack qty Price PO495A 90 10 5.90 Malt extract agar Catalogue No Plate diameter, mm Pack qty Price PO182A 90 10 6.38 MRSA agar Catalogue No Plate diameter, mm Pack qty Price OXPO1162A 90 10 15.49 Nutrient agar Catalogue No Plate diameter, mm Pack qty Price PO155A 90 10 5.75 Plate count agar Catalogue No Plate diameter, mm Pack qty Price PO158A 90 10 6.36 R2A agar Catalogue No Plate diameter, mm Pack qty Price PO659A 90 10 6.50 Sabouraud dextrose agar Catalogue No Plate diameter, mm Pack qty Price OXPO0160A 90 10 5.54 Sorbitol MacConkey agar Catalogue No Plate diameter, mm Pack qty Price PO232A 90 10 5.84 Tryptone soya agar Catalogue No Plate diameter, mm Pack qty Price PO163A 90 10 5.49 OXPO0193-C 55 10 10.91 Yeast extract agar Catalogue No Plate diameter, mm Pack qty Price PO441A 90 10 5.08 55.
    [Show full text]
  • BD Biosciences New RUO Reagents - November 2020
    BD Biosciences New RUO reagents - November 2020 Reactivity Description Format Clone Size Cat. number Hu CD133 FITC W6B3C1 100µg 567029 Hu CD133 FITC W6B3C1 25µg 567033 Hu CD39 PE A1/CD39 100Tst 567156 Hu CD39 PE A1/CD39 25Tst 567157 Hu KIR2DL1/S1/S3/S5 PE HP-MA4 100Tst 567158 Hu KIR2DL1/S1/S3/S5 PE HP-MA4 25Tst 567159 Hu IL-22 Alexa Fluor® 647 MH22B2 100µg 567160 Hu IL-22 Alexa Fluor® 647 MH22B2 25µg 567161 Hu CD99 R718 TU12 50µg 751651 Hu CD161 R718 DX12 50µg 751652 Hu CD116 R718 HGMCSFR-M1 50µg 751653 Hu HLA-G R718 87G 50µg 751670 Hu CD27 R718 O323 50µg 751686 Hu CD80 (B7-1) R718 2D10.4 50µg 751737 Hu Integrin αvβ5 R718 ALULA 50µg 751738 Hu CD266 (Tweak-R) R718 ITEM-4 50µg 751739 Hu ErbB3 (HER-3) R718 SGP1 50µg 751799 Hu TCR Vβ5.1 R718 LC4 50µg 751816 Hu CD123 (IL-3Ra) R718 6H6 50µg 751844 Hu CD1a R718 SK9 50µg 751847 Hu CD20 R718 L27 50µg 751849 Hu Disial GD2 R718 14.G2A 50µg 751851 Reactivity Description Format Clone Size Cat. number Hu CD71 R718 L01.1 50µg 751853 Hu CD278 (ICOS) R718 DX29 50µg 751854 Hu B7-H4 R718 MIH43 50µg 751857 Hu CD53 R718 HI29 50µg 751858 Hu CD197 (CCR7) R718 2-L1-A 50µg 751859 Hu CD197 (CCR7) R718 3D12 50µg 751861 Hu CD31 R718 L133.1 50µg 751863 Hu EGF Receptor R718 EMAB-134 50µg 751864 Hu CD8b R718 2ST8.5H7 50µg 751867 Hu CD31 R718 MBC 78.2 50µg 751869 Hu CD162 R718 KPL-1 50µg 751873 Hu CD24 R718 ML5 50µg 751874 Hu CD159C (NKG2C) R718 134591 50µg 751876 Hu CD169 (Siglec-1) R718 7-239 50µg 751877 Hu CD16b R718 CLB-GRAN11.5 50µg 751880 Hu IgM R718 UCH-B1 50µg 751881 Hu CD275 R718 2D3/B7-H2 50µg 751883 Hu CD307e
    [Show full text]
  • Profound Treg Perturbations Correlate with COVID-19 Severity
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.11.416180; this version posted December 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Profound Treg perturbations correlate with COVID-19 severity Silvia Galván-Peña1*, Juliette Leon1,2*, Kaitavjeet Chowdhary1, Daniel A. Michelson1, Brinda Vijaykumar1, Liang Yang1, Angela Magnuson1, Zachary Manickas-Hill3,4, Alicja Piechocka- Trocha3,4, Daniel P. Worrall3,4, Kathryn E. Hall3,5, Musie Ghebremichael3,4, Bruce D. Walker3,4,6, Jonathan Z. Li3,7, Xu G. Yu3,4, MGH COVID-19 Collection & Processing Team, Diane Mathis1 and Christophe Benoist1,8,+ 1Department of Immunology, Harvard Medical School, Boston, MA, USA 2 INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France 3Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA 4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA 5Department of Medicine, Massachusetts General Hospital, Boston, MA, USA 6Howard Hughes Medical Institute, Center for the AIDS Programme of Research in South Africa. 7Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 8Lead contact * Equal contribution +Address correspondence to: Christophe Benoist Department of Immunology Harvard Medical School 77 Avenue Louis Pasteur, Boston, MA 02115 e-mail: [email protected] Phone: (617) 432-7741 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.11.416180; this version posted December 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Gene List HTG Edgeseq Immuno-Oncology Assay
    Gene List HTG EdgeSeq Immuno-Oncology Assay Adhesion ADGRE5 CLEC4A CLEC7A IBSP ICAM4 ITGA5 ITGB1 L1CAM MBL2 SELE ALCAM CLEC4C DST ICAM1 ITGA1 ITGA6 ITGB2 LGALS1 MUC1 SVIL CDH1 CLEC5A EPCAM ICAM2 ITGA2 ITGAL ITGB3 LGALS3 NCAM1 THBS1 CDH5 CLEC6A FN1 ICAM3 ITGA4 ITGAM ITGB4 LGALS9 PVR THY1 Apoptosis APAF1 BCL2 BID CARD11 CASP10 CASP8 FADD NOD1 SSX1 TP53 TRAF3 BCL10 BCL2L1 BIRC5 CASP1 CASP3 DDX58 NLRP3 NOD2 TIMP1 TRAF2 TRAF6 B-Cell Function BLNK BTLA CD22 CD79A FAS FCER2 IKBKG PAX5 SLAMF1 SLAMF7 SPN BTK CD19 CD24 EBF4 FASLG IKBKB MS4A1 RAG1 SLAMF6 SPI1 Cell Cycle ABL1 ATF1 ATM BATF CCND1 CDK1 CDKN1B NCL RELA SSX1 TBX21 TP53 ABL2 ATF2 AXL BAX CCND3 CDKN1A EGR1 REL RELB TBK1 TIMP1 TTK Cell Signaling ADORA2A DUSP4 HES1 IGF2R LYN MAPK1 MUC1 NOTCH1 RIPK2 SMAD3 STAT5B AKT3 DUSP6 HES5 IKZF1 MAF MAPK11 MYC PIK3CD RNF4 SOCS1 STAT6 BCL6 ELK1 HEY1 IKZF2 MAP2K1 MAPK14 NFATC1 PIK3CG RORC SOCS3 SYK CEBPB EP300 HEY2 IKZF3 MAP2K2 MAPK3 NFATC3 POU2F2 RUNX1 SPINK5 TAL1 CIITA ETS1 HEYL JAK1 MAP2K4 MAPK8 NFATC4 PRKCD RUNX3 STAT1 TCF7 CREB1 FLT3 HMGB1 JAK2 MAP2K7 MAPKAPK2 NFKB1 PRKCE S100B STAT2 TYK2 CREB5 FOS HRAS JAK3 MAP3K1 MEF2C NFKB2 PTEN SEMA4D STAT3 CREBBP GATA3 IGF1R KIT MAP3K5 MTDH NFKBIA PYCARD SMAD2 STAT4 Chemokine CCL1 CCL16 CCL20 CCL25 CCL4 CCR2 CCR7 CX3CL1 CXCL12 CXCL3 CXCR1 CXCR6 CCL11 CCL17 CCL21 CCL26 CCL5 CCR3 CCR9 CX3CR1 CXCL13 CXCL5 CXCR2 MST1R CCL13 CCL18 CCL22 CCL27 CCL7 CCR4 CCRL2 CXCL1 CXCL14 CXCL6 CXCR3 PPBP CCL14 CCL19 CCL23 CCL28 CCL8 CCR5 CKLF CXCL10 CXCL16 CXCL8 CXCR4 XCL2 CCL15 CCL2 CCL24 CCL3 CCR1 CCR6 CMKLR1 CXCL11 CXCL2 CXCL9 CXCR5
    [Show full text]
  • The Expression and Regulation of Chemerin in the Epidermis
    RESEARCH ARTICLE The Expression and Regulation of Chemerin in the Epidermis Magdalena Banas1, Aneta Zegar1, Mateusz Kwitniewski1, Katarzyna Zabieglo1, Joanna Marczynska1, Monika Kapinska-Mrowiecka2, Melissa LaJevic3,4, Brian A. Zabel4, Joanna Cichy1* 1 Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland, 2 Department of Dermatology, Zeromski Hospital, Kraków, Poland, 3 Stanford University School of Medicine, Department of Pathology, Stanford, California, United States of America, 4 Palo Alto Veterans Institute for Research, VA Palo Alto Health Care System, Palo Alto, California, United States of America * [email protected] Abstract OPEN ACCESS Chemerin is a protein ligand for the G protein-coupled receptor CMKLR1 and also binds to two atypical heptahelical receptors, CCRL2 and GPR1. Chemerin is a leukocyte attractant, Citation: Banas M, Zegar A, Kwitniewski M, Zabieglo K, Marczynska J, Kapinska-Mrowiecka M, et al. adipokine, and antimicrobial protein. Although chemerin was initially identified as a highly (2015) The Expression and Regulation of Chemerin expressed gene in healthy skin keratinocytes that was downregulated during psoriasis, the in the Epidermis. PLoS ONE 10(2): e0117830. regulation of chemerin and its receptors in the skin by specific cytokines and microbial fac- doi:10.1371/journal.pone.0117830 tors remains unexplored. Here we show that chemerin, CMKLR1, CCRL2 and GPR1 are Academic Editor: Bernhard Ryffel, French National expressed in human and mouse epidermis, suggesting that this tissue may be both a Centre for Scientific Research, FRANCE source and target for chemerin mediated effects. In human skin cultures, chemerin is signifi- Received: October 1, 2014 cantly downregulated by IL-17 and IL-22, key cytokines implicated in psoriasis, whereas it is Accepted: December 31, 2014 upregulated by acute phase cytokines oncostatin M and IL-1β.
    [Show full text]
  • Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association Between BMI and Adult-Onset Non- Atopic
    Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association between BMI and Adult-Onset Non- Atopic Asthma Ayoung Jeong 1,2, Medea Imboden 1,2, Akram Ghantous 3, Alexei Novoloaca 3, Anne-Elie Carsin 4,5,6, Manolis Kogevinas 4,5,6, Christian Schindler 1,2, Gianfranco Lovison 7, Zdenko Herceg 3, Cyrille Cuenin 3, Roel Vermeulen 8, Deborah Jarvis 9, André F. S. Amaral 9, Florian Kronenberg 10, Paolo Vineis 11,12 and Nicole Probst-Hensch 1,2,* 1 Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; [email protected] (A.J.); [email protected] (M.I.); [email protected] (C.S.) 2 Department of Public Health, University of Basel, 4001 Basel, Switzerland 3 International Agency for Research on Cancer, 69372 Lyon, France; [email protected] (A.G.); [email protected] (A.N.); [email protected] (Z.H.); [email protected] (C.C.) 4 ISGlobal, Barcelona Institute for Global Health, 08003 Barcelona, Spain; [email protected] (A.-E.C.); [email protected] (M.K.) 5 Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain 6 CIBER Epidemiología y Salud Pública (CIBERESP), 08005 Barcelona, Spain 7 Department of Economics, Business and Statistics, University of Palermo, 90128 Palermo, Italy; [email protected] 8 Environmental Epidemiology Division, Utrecht University, Institute for Risk Assessment Sciences, 3584CM Utrecht, Netherlands; [email protected] 9 Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College, SW3 6LR London, UK; [email protected] (D.J.); [email protected] (A.F.S.A.) 10 Division of Genetic Epidemiology, Medical University of Innsbruck, 6020 Innsbruck, Austria; [email protected] 11 MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, W2 1PG London, UK; [email protected] 12 Italian Institute for Genomic Medicine (IIGM), 10126 Turin, Italy * Correspondence: [email protected]; Tel.: +41-61-284-8378 Int.
    [Show full text]
  • Microbiological and Metagenomic Characterization of a Retail Delicatessen Galotyri-Like Fresh Acid-Curd Cheese Product
    fermentation Article Microbiological and Metagenomic Characterization of a Retail Delicatessen Galotyri-Like Fresh Acid-Curd Cheese Product John Samelis 1,* , Agapi I. Doulgeraki 2,* , Vasiliki Bikouli 2, Dimitrios Pappas 3 and Athanasia Kakouri 1 1 Dairy Research Department, Hellenic Agricultural Organization ‘DIMITRA’, Katsikas, 45221 Ioannina, Greece; [email protected] 2 Hellenic Agricultural Organization ‘DIMITRA’, Institute of Technology of Agricultural Products, 14123 Lycovrissi, Greece; [email protected] 3 Skarfi EPE—Pappas Bros Traditional Dairy, 48200 Filippiada, Greece; [email protected] * Correspondence: [email protected] (J.S.); [email protected] (A.I.D.); Tel.: +30-2651094789 (J.S.); +30-2102845940 (A.I.D.) Abstract: This study evaluated the microbial quality, safety, and ecology of a retail delicatessen Galotyri-like fresh acid-curd cheese traditionally produced by mixing fresh natural Greek yogurt with ‘Myzithrenio’, a naturally fermented and ripened whey cheese variety. Five retail cheese batches (mean pH 4.1) were analyzed for total and selective microbial counts, and 150 presumptive isolates of lactic acid bacteria (LAB) were characterized biochemically. Additionally, the most and the least diversified batches were subjected to a culture-independent 16S rRNA gene sequencing analysis. LAB prevailed in all cheeses followed by yeasts. Enterobacteria, pseudomonads, and staphylococci were present as <100 viable cells/g of cheese. The yogurt starters Streptococcus thermophilus and Lactobacillus delbrueckii were the most abundant LAB isolates, followed by nonstarter strains of Lactiplantibacillus, Lacticaseibacillus, Enterococcus faecium, E. faecalis, and Leuconostoc mesenteroides, Citation: Samelis, J.; Doulgeraki, A.I.; whose isolation frequency was batch-dependent. Lactococcus lactis isolates were sporadic, except Bikouli, V.; Pappas, D.; Kakouri, A. Microbiological and Metagenomic for one cheese batch.
    [Show full text]
  • Malaria Polyclonal B Cell Activator Activation of the Memory
    Increased B Cell Survival and Preferential Activation of the Memory Compartment by a Malaria Polyclonal B Cell Activator This information is current as Daria Donati, Bobo Mok, Arnaud Chêne, Hong Xu, Mathula of October 2, 2021. Thangarajh, Rickard Glas, Qijun Chen, Mats Wahlgren and Maria Teresa Bejarano J Immunol 2006; 177:3035-3044; ; doi: 10.4049/jimmunol.177.5.3035 http://www.jimmunol.org/content/177/5/3035 Downloaded from References This article cites 35 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/177/5/3035.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 2, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Increased B Cell Survival and Preferential Activation of the Memory Compartment by a Malaria Polyclonal B Cell Activator1 Daria Donati,2† Bobo Mok,* Arnaud Cheˆne,*† Hong Xu,† Mathula Thangarajh,‡ Rickard Glas,† Qijun Chen,§ Mats Wahlgren,* and Maria Teresa Bejarano*† Chronic malaria infection is characterized by polyclonal B cell activation, hyperglobulinemia, and elevated titers of autoantibod- ies.
    [Show full text]
  • Program in Lupus Monocytes to Turn on a Migratory Dendritic Cell IFN
    IFN Priming Is Necessary but Not Sufficient To Turn on a Migratory Dendritic Cell Program in Lupus Monocytes This information is current as Alicia Rodriguez-Pla, Pinakeen Patel, Holden T. Maecker, of September 28, 2021. Jose Rossello-Urgell, Nicole Baldwin, Lynda Bennett, Victoria Cantrell, Jeanine Baisch, Marilynn Punaro, Alisa Gotte, Lorien Nassi, Tracey Wright, Anna Karolina Palucka, Jacques Banchereau and Virginia Pascual J Immunol 2014; 192:5586-5598; Prepublished online 14 Downloaded from May 2014; doi: 10.4049/jimmunol.1301319 http://www.jimmunol.org/content/192/12/5586 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2014/05/14/jimmunol.130131 Material 9.DCSupplemental References This article cites 70 articles, 26 of which you can access for free at: http://www.jimmunol.org/content/192/12/5586.full#ref-list-1 Why The JI? Submit online. by guest on September 28, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Food Microbiology
    Food Microbiology Food Water Dairy Beverage Online Ordering Available Food, Water, Dairy, & Beverage Microbiology Table of Contents 1 Environmental Monitoring Contact Plates 3 Petri Plates 3 Culture Media for Air Sampling 4 Environmental Sampling Boot Swabs 6 Environmental Testing Swabs 8 Surface Sanitizers 8 Hand Sanitation 9 Sample Preparation - Dilution Vials 10 Compact Dry™ 12 HardyCHROM™ Chromogenic Culture Media 15 Prepared Media 24 Agar Plates for Membrane Filtration 26 CRITERION™ Dehydrated Culture Media 28 Pathogen Detection Environmental With Monitoring Contact Plates Baird Parker Agar Friction Lid For the selective isolation and enumeration of coagulase-positive staphylococci (Staphylococcus aureus) on environmental surfaces. HardyCHROM™ ECC 15x60mm contact plate, A chromogenic medium for the detection, 10/pk ................................................................................ 89407-364 differentiation, and enumeration of Escherichia coli and other coliforms from environmental surfaces (E. coli D/E Neutralizing Agar turns blue, coliforms turn red). For the enumeration of environmental organisms. 15x60mm plate contact plate, The media is able to neutralize most antiseptics 10/pk ................................................................................ 89407-354 and disinfectants that may inhibit the growth of environmental organisms. Malt Extract 15x60mm contact plate, Malt Extract is recommended for the cultivation and 10/pk ................................................................................89407-482
    [Show full text]
  • Isolation, Identification and Investigation Of
    foods Article Isolation, Identification and Investigation of Fermentative Bacteria from Sea Bass (Dicentrarchus labrax): Evaluation of Antifungal Activity of Fermented Fish Meat and By-Products Broths Francisco J. Martí-Quijal 1 , Andrea Príncep 1, Adrián Tornos 1 , Carlos Luz 1, Giuseppe Meca 1, Paola Tedeschi 2, María-José Ruiz 1, Francisco J. Barba 1,* and Jordi Mañes 1 1 Nutrition, Food Science and Toxicology Department, Faculty of Pharmacy, Universitat de València, Avda. Vicent Andrés Estellés, s/n, 46100 Burjassot, València, Spain; [email protected] (F.J.M.-Q.); [email protected] (A.P.); [email protected] (A.T.); [email protected] (C.L.); [email protected] (G.M.); [email protected] (M.-J.R.); [email protected] (J.M.) 2 Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Fossato di Mortara 17, 44121 Ferrara, Italy; [email protected] * Correspondence: [email protected] Received: 2 April 2020; Accepted: 17 April 2020; Published: 4 May 2020 Abstract: During fish production processes, great amounts of by-products are generated, representing 30–70% of the initial weight. Thus, this research study is investigating 30 lactic acid bacteria ≈ (LAB) derived from the sea bass gastrointestinal tract, for anti-fungal activity. It has been previously suggested that LAB showing high proteolitic activity are the most suitable candidates for such an investigation. The isolation was made using a MRS (Man Rogosa Sharpe) broth cultivation medium at 37 ºC under anaerobiosis conditions, while the evaluation of the enzymatic activity was made using the API® ZYM kit.
    [Show full text]
  • KRAS Mutations Are Negatively Correlated with Immunity in Colon Cancer
    www.aging-us.com AGING 2021, Vol. 13, No. 1 Research Paper KRAS mutations are negatively correlated with immunity in colon cancer Xiaorui Fu1,2,*, Xinyi Wang1,2,*, Jinzhong Duanmu1, Taiyuan Li1, Qunguang Jiang1 1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China 2Queen Mary College, Medical Department, Nanchang University, Nanchang, Jiangxi, People's Republic of China *Equal contribution Correspondence to: Qunguang Jiang; email: [email protected] Keywords: KRAS mutations, immunity, colon cancer, tumor-infiltrating immune cells, inflammation Received: March 27, 2020 Accepted: October 8, 2020 Published: November 26, 2020 Copyright: © 2020 Fu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT The heterogeneity of colon cancer tumors suggests that therapeutics targeting specific molecules may be effective in only a few patients. It is therefore necessary to explore gene mutations in colon cancer. In this study, we obtained colon cancer samples from The Cancer Genome Atlas, and the International Cancer Genome Consortium. We evaluated the landscape of somatic mutations in colon cancer and found that KRAS mutations, particularly rs121913529, were frequent and had prognostic value. Using ESTIMATE analysis, we observed that the KRAS-mutated group had higher tumor purity, lower immune score, and lower stromal score than the wild- type group. Through single-sample Gene Set Enrichment Analysis and Gene Set Enrichment Analysis, we found that KRAS mutations negatively correlated with enrichment levels of tumor infiltrating lymphocytes, inflammation, and cytolytic activities.
    [Show full text]